JP Morgan Maintains Overweight on Molina Healthcare, Lowers Price Target to $420
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Lisa Gill maintains an Overweight rating on Molina Healthcare (NYSE:MOH) but lowers the price target from $435 to $420.
May 30, 2024 | 6:20 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan analyst Lisa Gill maintains an Overweight rating on Molina Healthcare but lowers the price target from $435 to $420.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100